Carbapenemase-producing Gram-negative organisms currently constitute a severe public health problem. Among them, the most ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

In nature as well as in our bodies, bacteria predominantly live as organized communities called biofilms. These structures ...

The continuing rise of multidrug resistant pathogens has made it clear that in the absence of new antibiotics we are moving toward a “postantibiotic” world, in which even routine infections will ...

ASU professor Glen D’Souza joined The Show to speak more about what he’s discovered about these bacteria: Not only will ...

The Mayo Clinic lists symptoms of the early stage occurring three to 30 days after an infected tick has bitten you.

C reactive protein (CRP), a marker for the presence of an inflammatory process, is the most extensively studied marker for distinguishing bacterial from non-bacterial infections in febrile patients. A ...

However, the market for antibiotics is failing due to limited sales volumes, generic competition, and inadequate recognition of their value. In this report, we describe the design of a globally ...